Sign in with Google
bullish
Korea Synthetic Stubs: C&T at 2-Yr Low, Pure Stub Trade with Biologics
328 Views14 Jun 2020 22:26
Out of the five synthetic stubs in Korea, two names are in a severe diversion at this point.They are Samsung C&T and CJ Corp.C&T is now at...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »- ShinKong (2888 TT)/Taishin (2887 TT) - Time To Deal Is Shorter, But Risk To Peers Is Higher
- Hang Seng Indexes: ADR Depositary Holding Changes; Round-Trip Trade Is US$5.1bn; NetEase Outperforms
- CATL: Launch of Book Building for Hong Kong Listing
- Rare Arb Opportunity from ATS Breakout in Korea: Day-Night Spread
- Gold Road Enters Scheme With Gold Fields
Top Unpaywalled Insights
More »Loading
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Samsung Biologics Contract Manufacturing Deal with Moderna for COVID-19 Vaccines: Key Takeaways14 May 2021
- Samsung Biologics CMO Deal Noise & Samsung C&T Synthetic Subsidiary Stub Trade12 May 2021
- Why Are Local Institutions Buying Samsung C&T Instead of Life over Elec Stake Sale?18 Aug 2020
- Korea Synthetic Stubs: C&T at 2-Yr Low, Pure Stub Trade with Biologics14 Jun 2020
- Samsung 1P Discount: Biologics/Elec Equity Swap Dynamics04 Jun 2020
- Samsung 1P Discount Now at an All-Time Low: Why & What Next25 May 2020
x